Immunomodulatory injectable silk hydrogels maintaining functional islets and promoting anti-inflammatory M2 macrophage polarization

• Published in: Biomaterials Vol. 187; pp. 1 - 17
• Main Authors: Kumar, Manishekhar, Gupta, Prerak, Bhattacharjee, Sohenii, Nandi, Samit K., Mandal, Biman B.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-12-2018
• Subjects: Immunomodulation; Injectable hydrogel; Islet encapsulation; Self-gelation; Silk; Tissue engineering; Silk; Islet encapsulation; Immunomodulation; Tissue engineering; Injectable hydrogel; Self-gelation
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2018.09.037

Islet transplantation is considered the most promising treatment for type 1 diabetes. However, the clinical success is limited by islet dysfunction in long-term culture. In this study, we have utilized the rapid self-gelation and injectability offered by blending of mulberry silk (Bombyx mori) with non-mulberry (Antheraea assama) silk, resulting in a biomimetic hydrogel. Unlike the previously reported silk gelation techniques, the differences in amino acid sequences of the two silk varieties result in accelerated gelation without requiring any external stimulus. Gelation study and rheological assessment depicts tuneable gelation as a function of protein concentration and blending ratio with minimum gelation time. In vitro biological results reveal that the blended hydrogels provide an ideal 3D matrix for primary rat islets. Also, A. assama fibroin with inherent Arg-Gly-Asp (RGD) shows significant influence on islet viability, insulin secretion and endothelial cell maintenance. Furthermore, utility of these hydrogels demonstrate sustained release of Interleukin-4 (IL-4) and Dexamethasone with effective M2 macrophage polarization while preserving islet physiology. The immuno-informed hydrogel demonstrates local modulation of inflammatory responses in vivo. Altogether, the results exhibit promising attributes of injectable silk hydrogel and the utility of non-mulberry silk fibroin as an alternative biomaterial for islet encapsulation.
[Display omitted]